Answers are grounded in this paper and cite their sources.
Observational analysis finds correlations between gut microbiota metabolites and CAR-T therapy outcomes in multiple myeloma, suggesting potential biomarkers.
Supplementary Figure S3 presents the pre-CAR T-cell infusion gut fecal metabolite profiles detected in multiple myeloma patients, showing means ± standard deviation for each metabolite.
No takes yet. Share an insight, caveat, or question.
Uribe‐Herranz et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: